Cross-contamination with previously amplified products poses a serious limitation In the use of PCR for clinical testing and In certain research applications as well. In the present study we report the use of novel primers containing a 3'-termlnal ribose residue to circumvent this problem. Extension of the primer by Taq DNA polymerase generates a cleavable ribonucleotide linkage within the amplified product. Cleavage of the primer by base or with a ribonuclease interferes with further replication of the product should carry over to another sample occur. Primers terminating In any of the 4 ribose residues function equally well as all DNA primers. Taq DNA polymerase is thus able to both efficiently extend and copy the single ribose residue. In translating from all DNA primers to ones containing a 3'-rlbose residue no modification of the PCR protocol Is required. The products formed can be used in all applications of the PCR. Since neither the original sample DNA, the primers or the extension products are modified by base or ribonuclease treatment both pre-and postamplification sterilization can be carried out. Preamplification treatment with RNase A can yield as high as 10Mold sterilization. Under these conditions the addition of /3-mercaptoethanol or other sulfhydryl reducing agent is necessary to inactivate the enzyme during thermocycllng. Post-amplification treatment with NaOH readily yields at least 10 8 -fold sterilization. This alone Is sufficient for most, if not all, applications of PCR. It is especially useful for quantitative RT-PCR, since the original target RNA sequence, which may be present in high copy numbers, Is also destroyed.
INTRODUCTION
A number of nucleic acid amplification procedures have been devised which enable the detection of a very low copy number of the target sequence. The most widely used of these is the polymerase chain reaction, PCR (1-3). As many as 10 12 molecules of the amplified product can be produced in a 100 /tl reaction. The generation of such high copy numbers of the amplicon, however, may give rise to serious contamination problems which have limited the use of the PCR in clinical diagnostic assays and poses a problem in certain research applications as well. At a concentration of 10 12 copies per 100 li\, 1 picoliter (10~6 /*1) contains 10,000 molecules. Transfer of such small volumes to other samples either by aerosolizan'on or mechanical means is very difficult to avoid. This renders assay systems based on the PCR extremely susceptible to false positive results even with rigorous containment procedures.
Several approaches have been devised to deal with the problem of PCR cross-contamination. In one method, dUTP is incorporated into the extension product allowing it to be selectively destroyed with the enzyme uracil N-glycosylase (UNG) (4) . However, dUTP is an expensive reagent, and in some cases it is utilized less efficiently as a substrate by Taq DNA polymerase than TTP leading to lower levels of amplification (4) . Moreover, since UNG destroys the product, it is useful in practice only for pre-amplification sterilization. It could be used after detection of the product but the possibility of contamination during the assay of other samples prior to their being amplified poses difficulties. A second method involves the use of isopsoralen derivatives which undergo a cycloaddition reaction with thymidine residues of the amplicon upon exposure to UV light (5, 6) . This renders the DNA incapable of acting as a template for further replication, but it still remains detectable in hybridization assays. Aside from requiring the use of carcinogenic reagents, the efficiency of the method is very dependent on the sequence and lengdi of the target. Because the sample DNA would also be modified, it can only be carried out following amplification.
In the present study, we describe a novel approach to circumventing the problem of cross-contamination associated with the PCR by the use of primers which contain a 3'-terminal ribose residue (see Fig. 1 ). Primers ending with any of the four ribose residues serve equally well as their all DNA counterparts in the PCR. Extension of the primer generates a cleavable ribonucleotide linkage within the amplicon. Cleavage of the primers from the product either enzymaticaUy or with base prevents further exponential amplification of the product. Since 
R Figure 1 . Schematic diagram outlining the process by which 3'-ribose PCR primers provide effective sterilization. Oligonucleotides X and Y are the primers used for amplification. R designates the ribose residue at the 3'-ends of the primers. The ribonucleotide linkages generated in the extension reaction allow the primers to be readily cleaved from the amplicon either by treatment with base or a ribonuclease. It is not immediately apparent that cleavage of the primers alone would lead to effective sterilization. The fragments A' and B' generated after the primers have been cleaved retain binding sites at their 3' ends for primers Y and X, respectively, and can be copied reactions (1) and (2) . However, the resulting fragments C and D are dead end products. I arlring primer binding sites at their 3 '-ends, they cannot be further replicated. Linear amplification of carryover fragments A' and B' is rapidly drowned out by exponential amplification of any true target sequences present in the sample and does not cause a background problem. For example, even if 10 5 amplicons were carried over to another sample, after 30 cycles of the PCR at most 3 X10* copies of C and D would be produced. This could be set below the detection limit of the assay. On the other hand, if only 10 copies of the native target sequence were present, after 30 cycles of the PCR over 10 9 copies of the product would be formed (assuming a typical amplification efficiency of 0.85) and a true positive result would be obtained in the subsequent assay. There is a second, more subtle, reaction which might be thought to undermine the sterilization process. Fragments C and D can in principle hybridize to one another, and by extension of their 3'-ends regenerate the complete amplicon which again would be capable of exponential amplification. In practice, this does not occur most probably because the concentrations of C and D are so low. 3x 10 6 molecules in 100 /d (the usual reaction volume for the PCR) corresponds to a concentration of only 5xl0~1 4 M. This is approximately 7 orders of magnitude lower than the concentration of primers used in the PCR to drive the annealing reaction at a reasonable rate. The reaction, therefore, is prevented for kinetic reasons.
the cleavable linkage does not pre-exist within the primer, sterilization can be carried out either pre-or post-amplification, or at both steps. With post-amplification base treatment alone at least K^-fold sterilization can be achieved, a level sufficient to eliminate the problem of trace carry over contamination in most, if not all, PCR applications.
MATERIALS AND METHODS Materials
Taq DNA polymerase (AmpliTaq R ) was obtained from PerkinElmer Cetus. RNase A was purchased from Boehringer Mannheim. T4 polynucleotide kinase and deoxynucleotide triphosphates were from Pharmacia, y ^-ATP (3000 Ci/mmol) was obtained from Amersham. Human cytomegalovirus (CMV) DNA isolated from the Towne strain was kindly provided by Mark Stinski.
Oligonucleotide synthesis
Oligonucleotides were synthesized on an ABI Model 381A DNA synthesizer using the standard phosphoramidite method. RNA control pore glass (Peninsula Labs) was used as the solid support for the synthesis of the 3'-terminal ribose primers. The chemistry and deprotection procedures used in the preparation of these oligonucleotides were the same as those for all DNA primers. No changes are required because with the RNA residue at the 3'-terminus there are no ribonucleotide linkages within the oligonucleotide.
PCR conditions
The PCR was carried out either with an Ericomp Twin Block System or in a Perkin-Elmer Cetus Model 9600 thermocycler. The temperature program used on the Ericomp system was 2 min at94°C, 1.5 min at 60°C and 1 min at 72°C. The program used on the Model 9600 was 5 sec at 94°C, 15 sec at 55°C and 10 sec at 72°C. Amplification reactions on the Ericomp were performed in the presence of 0.5 /*M primers, 200 nM dNTPs, 67 mM Tris-HCl pH 8.0 (measured at room temperature), 3 mM MgCl 2 , 170 /xg/ml bovine serum albumin, and 2.5 units of Taq DNA polymerase in a total volume of 10011. In studies using RNase A 10 mM /3-mercaptoethanol was also added. The samples were overlayed with 100 ^1 of light mineral oil. For the 9600 thermocycler the reaction buffer was 10 mM Tris-HCl pH 8.5, 50 mM KC1 with 2.5 mM MgCl 2 . All other components of the reaction mixture were the same as used with the Ericomp system except that bovine serum albumin was omitted. In all cases comparisons between 3'-ribose primers and all DNA primers were made under identical reaction conditions.
Detection of the PCR products
All of the CMV primers used amplify a fragment of approximately 130 base pairs from the immediate early region of the virus (see Table 1 ). The product was analyzed by electrophoresis on a 2.5% agarose gel containing 0.5 fig/id ethidium bromide.
Base hydrolysis of the CMV amplicon generated with 3'-ribose primers To determine whether the 3 '-terminal ribose residue of the primer was retained within the PCR product, the CMV amplicon that had been produced with primers ending in rC (1 and 2, see Table  1 ) was radiolabeled and subjected to alkaline hydrolysis. The amplicon was end labeled with T4 polynucleotide kinase and y 32 P ATP, and then treated with different concentrations of NaOH for 10 min at 95°C. After neutralization the products of the reaction were analyzed by electrophoresis on a 20% polyacrylamide-7M urea gel. An autoradiograph of the gel was obtained by exposure to Kodak XAR5 film at -70°C.
Dot blot hybridization of CMV amplicon treated with base
The CMV amplicon (50 ng) generated with primers ending in rG (5 and 6, see Table 1 ) was treated with different concentrations of NaOH for various times at 95°C (see Fig. 6 ). Afterwards, the DNA was neutralized with three volumes of cold 2M ammonium acetate, 1 /tg of yeast tRNA was then added, and the solutions were transferred in duplicate by vacuum filtration using the Bio-Rad dot blot manifold to a 9 X12 cm piece of Gene Screen Plus membrane (NEN-DuPont) equilibrated with 1 M ammonium acetate. The membrane was air dried, baked 2 hours at 80°C, and prehybridized in 2.5 ml rapid hybridization buffer (Amersham) for 30 min at 37°C. Following the prehybridization, 1 pmol of a ^P-end labelled internal oligonucleotide probe (5'CGCCATCCACGCTGTTTTGACC) was added to 2.5 ml of rapid hybridization buffer equilibrated at 37°C and incubated with the membrane for an additional hour at 37°C. The filter was first washed twice with 1XSSC, 0.1 % SDS at 37°C then once with O.lxSSC, 0.1% SDS at 37°C, dried and exposed for autoradiography with Kodak XAR5 film.
RESULTS
The efficiency of the PCR with 3'-ribose primers Fig. 2 compares the efficiency of amplification by the PCR with primers terminating in each of the four ribose residues to that with the corresponding all DNA primers. In each case a sequence of about 130 bp was amplified from the immediate early region of human CMV DNA. The viral DNA was present at an initial copy number of 10 6 and 30 cycles of the PCR were performed. There were no differences in the other components of the reaction mixture or the temperature program used for the 3 '-ribose primers and the standard DNA primers. As can be seen in Fig. 2 the level of amplification obtained with each of the 3'-ribose primers was essentially the same as that with their all DNA counterparts. We have observed this same equivalence down to 10 2 copies with primers directed to the gag region of HTV-1 in which one of the primers was end-labeled with 32 P for greater sensitivity (not shown). Equivalent amplification efficiency between 3'-ribose and all DNA primers has also been observed down to essentially single copy target detection using Southern blotting in which the amplified fragment was a 156 base pair sequence within the 3'-end of the OSP gene of Borrelia burgdorfu, the agent of lyme disease (David Persing, personal communication).
The 3'-ribose residue of the primer is retained within the amplicon A trivial explanation for the efficiency of 3'-ribose primers in the PCR is that the terminal ribose residue is excised by Taq DNA polymerase. Although the enzyme lacks a 3'-to 5'-exonuclease proofreading activity, this has only been established for DNA at the 3'-end. To prove that extension occurred from the 3'-ribose residue the CMV amplified sequence generated with primers containing 3'-rC was analyzed by alkaline hydrolysis. With increasing concentrations of base the primers are completely cleaved from the amplicon (see Fig. 3 ). No degradation of the corresponding product generated with all DNA primers is observed when treated under identical conditions (data not shown). These results clearly establish that the ribose residue is not excised from the primer prior to extension and is retained within the amplicon.
Pre-amplification enzymatic sterilization with RNase A
To test the efficiency of this process the CMV ribose C containing amplicon was used as a substrate. Ten units of RNase A were added to the standard PCR reaction mix including the primers. Since the ribose residue is at its 3'-terminus, the primers are not affected by treatment with the enzyme. 10 8 heat denatured molecules of the amplicon were then added. The sample was incubated for 15 min at 50°C and then amplified with 35 cycles of the PCR. Table 1 ), co-migrate. high temperatures of thermocycling yielding a 2'-5' phosphate linkage resistant to cleavage by the enzyme.
3 4 5

Post-amplification base sterilization
The rapidity with which base was observed to cleave the ribose linkage within the amplicon at elevated temperatures (see Fig. 3 ) suggested that this would provide a very effective and robust postamplification sterilization method. The CMV rC containing 1 2 3 4 5 6 7 8 Ml 2 3 45 67 89 10 11 Figure 4 . Pre-amplificarion enzymatic treatment of 10 8 molecules of a ribose containing amplicon with RNase A yielding 4-log sterilization. The amplified sequence was derived from CMV DNA by the PCR with 3'-ribose C primers (1 and 2, see Table 1 ). Reactions were amplified for 35 cycles with the Ericomp system (see Materials and Methods) and the products were run on a 2.5% agarose gel containing ethidium bromide. Lane 1, Hae III cut 0X174 DNA; lanes 2-6 titration curve, 10 8 , 10 7 , 10 6 , 10 3 , and 10 4 starting molecules, rcspectivdy. Lane 7, 10 8 molecules, untreated. Lane 8, 10 8 molecules treated with 10 units of RNase A in the complete PCR reaction mix prior to rhe PCR, followed by 35 cycles of amplification. The arrow points to the amplified product.
amplicon was again used as a substrate. A known concentration of the amplicon was dissolved in PCR reaction buffer and treated at 95°C with various concentrations of NaOH. After the reaction, the sample was neutralized with an equivalent amount of HC1, and a small aliquot was removed and then reamplified. The results of this study are shown in Fig. 5 . Treatment with 0.3 M NaOH for 1 hour at 95 °C results in a 4-log sterilization (lane 8). No product was detectable following treatment with 1 M NaOH for 1 hour or 2 M NaOH for 30 min. Comparison to the standard titration curve in lanes 1 through 6 shows that this represents at least a lO^fold level of sterilization; an easily detectable band is observed with a 5-log reduction (see lane 6).
The base treatment conditions used in Fig. 3 to demonstrate retention of the ribose residue in the product were much milder than those for sterilization. For effective sterilization the reaction must be driven far further to completion. For example, cleavage of 99% of the primers from the amplicon would lead to only a 2-log sterilization. The stronger base treatment, however, does not compromise the hybridization efficiency of the DNA (see Fig. 6 ).
DISCUSSION
The problem of cross-contamination has significantly hampered the realization of the use of the PCR in clinical diagnostics. It is a problem in certain research applications as well, particularly when the initial copy number of the target sequence is low and a large number of reaction cycles are needed to produce a detectable level of the amplified product. Carryover is also of obvious concern when the PCR is employed for quantitative purposes. The use of primers containing a 3'-terminal ribose residue provides a very simple and effective solution to these problems.
The introduction of a 3'-terminal ribose residue entails no increase in cost or difficulty in the synthesis of the primers. Exactly the same chemistry and procedures for deblocking and bp Figure 5 . Post-amplification base treatment of 10 s molecules of a 132 base pair ribose containing amplicon yields 6-log sterilization. The amplified sequence was derived from CMV DNA by the PCR using 3'-ribose C primers (1 and 2, Table  1 ). M, BioMarker™ low molecular weight standards (BioVentures, Inc.). Reactions were amplified for 30 cycles with the Perkin Elmer Cetus 9600 thermocycler and die PCR products were run on a 2.5% agarose gel containing ethidium bromide. Lanes 1-6, titration curve, 10 8 , 10 7 , 10 6 , 10 3 , 10 purification of the oligonucleotide are used as with all DNA primers. The solid support is simply replaced with one containing an RNA residue rather than one with a deoxynucleoside. These are available commercially. Since the ribonucleotide linkage does not pre-exist within the primer no special precautions in handling the oligonucleotide are necessary.
The efficiency of the PCR with 3'-ribose primers is the same as that with all DNA primers down to essentially single copy target detection. The results in Fig. 3, along with the high level of sterilization achievable with base, establish that the ribose residue is retained within the product. This indicates that Taq A second ribose residue adjacent to the 3' terminus can be incorporated in the primer (data not shown). However, the reverse transcriptase activity of Tag DNA polymerase is relatively weak. All RNA primers are essentially inactive. The introduction of additional cleavable linkages within the primer should increase the efficiency of sterilization. However, this adds greatly to the complexity of the synthesis and purification of the oligonucleotide, and would preclude the use of any pre-amplification sterilization method in which the primers were already added to the reaction mixture. Given the high level of sterilization efficiency which can be achieved with a single ribose, the incorporation of additional RNA residues within the primer would seem to be unwarranted.
Pre-amplification sterilization with RNase A, of course, requires drat the 3'-terminal ribose residue of the primers be C or U and that the strands be denatured during the preparation of the sample. The latter is already true for many of the methods used to isolate DNA, and if not, can simply be accomplished by a final heating step. RNase A is an extremely stable enzyme and can rapidly refold after thermal denaturation (7) . This is also true of many other small molecular weight single-stranded ribonucleases. If reactivation of the enzyme occurs during thermocycling the product would be destroyed as it is being formed. This is, in fact, a problem at times when using the UNG method; UNG is also a very stable enzyme. However, RNase A is rapidly and irreversibly inactivated by thermal denaturation in the presence of /3-mercaptoethanol or other sulfhydryl reducing agents (8) which do not affect the activity of Taq DNA polymerase.
Post-amplification treatment with base provides a far more robust and effective method for cross-contamination control than enzymatic sterilization, and is unaffected by the possibility of 3' -2' phosphate migration. A sterilization efficiency of at least K^-fold can readily be achieved. One potential drawback to this approach is that with current microcentrifuge tubes the lids would have to be opened to add the base, risking the possibility of aerosolization. This problem has been solved by the development of reaction tubes which allow addition of NaOH to the reaction mixture without opening (will be available from Integrated DNA Technologies, Inc.).
Post-amplification base treatment is also very useful with RT-PCR. Since the original target RNA sequence is generally present in relatively high copy number (a single mammalian cell may contain as many as 10 5 copies of one mRNA), direct crosscontamination by the sample RNA itself poses a serious problem. This is particularly true when RT-PCR is used for quantitative purposes. Post-amplification base treatment eliminates this mode of contamination as well since the extent of hydrolysis achieved completely destroys the target RNA.
The use of 3'-ribose containing primers in the PCR would seem to suffer from no disadvantages. The cost and difficulty of synthesis of these primers are no greater than that for all DNA primers. The efficiency and specificity of amplification is unaffected by replacement of the 3'-terminal deoxynucleotide with any of the four ribose residues. No change in the PCR protocol is required to use 3'-ribose primers. Many of the same detection methods post NaOH treatment can be employed as those for amplicons produced with all DNA primers. Amplicons generated with 3'-ribose primers can also be used for sequencing and cloning and all other research applications of PCR products.
The use of 3'-ribose primers affords options for both pre-and post-amplification sterilization of PCR products. Of these, the most advantageous is post-amplification base treatment. It is far the most robust and inexpensive of the sterilization procedures that have been developed for the PCR. With this method lf^-fold sterilization can be readily achieved. This alone should be sufficient for most, if not all, clinical applications of the PCR. If a higher level of sterilization should be needed in certain situations, this can be augmented with an independent preamplification decontamination procedure such as the UNG method. Post-amplification base treatment should also be of particular value for PT-PCR when used for quantitative purposes. In addition, the long 3'-overhanging sequence produced after cleavage of the primer provides a very facile means for cloning and site-directed mutagenesis. These methods will be described in more detail in a subsequent publication.
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